Anthrax other diagnostic studies

Jump to navigation Jump to search

Anthrax Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Anthrax from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Anthrax other diagnostic studies On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Anthrax other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Anthrax other diagnostic studies

CDC on Anthrax other diagnostic studies

Anthrax other diagnostic studies in the news

Blogs on Anthrax other diagnostic studies

Directions to Hospitals Treating Anthrax

Risk calculators and risk factors for Anthrax other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]

Overview

Important studies for the diagnosis and monitoring of anthrax patients include the PCR test for the confirmation of the virulence of the organism; lumbar puncture, when not contraindicated for search of the organism in the CSF, helping to exclude other diagnoses; EKG and echocardiogram to evaluate possible complications such as the atrial fibrillation and rule out pericardial effusion; along with other imaging studies to evaluate necrosis and/or inflammation.

Diagnostic Studies

Other studies to diagnose and monitor Anthrax infection and its potential complications include:[1][2]

Laboratory findings
Test Initial Findings Serial Monitoring
PCR Confirms virulence of organism by search for virulence factor genes
Primers to the toxin gene
Primer for the enzyme of capsule formation gene
Lumbar puncture At admission unless contraindicated Headache
Confusion
Other neurologic symptom
If meningitis, meningeal signs will only be present at a later stage
Other imaging As relevant to site of exposure
Evaluate edema
Evaluate inflammation
Evaluate necrosis
For headache, confusion or other neurologic symptom
If meningitis, meningeal signs will only be present at a later stage
EKG Atrial fibrillation with rapid ventricular response
Echocardiogram Evaluate for pericardial effusion
Evaluate for myocardial dysfunction

References

  1. Hendricks, Katherine A.; Wright, Mary E.; Shadomy, Sean V.; Bradley, John S.; Morrow, Meredith G.; Pavia, Andy T.; Rubinstein, Ethan; Holty, Jon-Erik C.; Messonnier, Nancy E.; Smith, Theresa L.; Pesik, Nicki; Treadwell, Tracee A.; Bower, William A. (2014). "Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults". Emerging Infectious Diseases. 20 (2). doi:10.3201/eid2002.130687. ISSN 1080-6040.
  2. "Anthrax in Humans and Animals" (PDF).